Literature DB >> 23273821

Real-time sonoelastography compared to magnetic resonance imaging using four different modalities at 3.0 T in the detection of prostate cancer: strength and weaknesses.

Alexandre E Pelzer1, Julia Heinzelbecker, Christel Weiß, Dominik Frühbauer, Anja M Weidner, Matthias Kirchner, Philipp Stroebel, Stephan O Schoenberg, Dietmar J Dinter.   

Abstract

OBJECTIVE: To compare the results of RTE with four different modalities at 3.0 T using endorectal and body phased array coil in the detection of PC. PATIENTS AND METHODS: Between May 2009 and July 2010, 50 patients with biopsy proven PC scheduled for radical prostatectomy (RP) were examined. All patients underwent RTE of the prostate and 3.0 T endorectal MRI. The investigators were unaware of the clinical data and of each others results.
RESULTS: RTE detected PC in 46 (92%) and MRI in 42 (84%) of the patients. Depending on the analysis sensitivity was 44.1-58.9% for RTE and 36.7-43.1% for MRI. Specificity was 83.0-74.8% for RTE and 85.9-79.8% for MRI. Sensitivity was significantly higher for RTE (16-sectors: p=0.0348; 8-sectors: p=0.0002) and showed better results in the dorsal (RTE: 51.9%; MRT: 37.7%) and apical to middle (RTE: 66.7%-80.0%; MRI: 41.7%-60.0%) parts of the prostate. MRI showed better results in the base (MRI: 19.4%; RTE: 14.9%) and transitional zone (TZ) (MRI: 34.7%; RTE: 29.6%). Concerning capsular involvement the results were comparable with sensitivity and specificity of RTE being 79.2% and 80.0% compared to 80.8% and 70.0% of MRI.
CONCLUSIONS: Concerning sensitivity RTE showed advantages in apical and middle parts whereas MRI may provide advantages in the glands' base and TZ. Both RTE and MRI have limitations particularly in basal and ventral parts. Most of the undetected tumours were of low tumour volume and Gleason Score. Considering capsular involvement both techniques showed comparable results.
Copyright © 2012 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 23273821     DOI: 10.1016/j.ejrad.2012.11.035

Source DB:  PubMed          Journal:  Eur J Radiol        ISSN: 0720-048X            Impact factor:   3.528


  9 in total

Review 1.  [Prostate biopsy: Procedure in the clinical routine].

Authors:  T Enzmann; T Tokas; K Korte; M Ritter; P Hammerer; L Franzaring; H Heynemann; H-W Gottfried; H Bertermann; M Meyer-Schwickerath; B Wirth; A Pelzer; T Loch
Journal:  Urologe A       Date:  2015-12       Impact factor: 0.639

Review 2.  Real-time elastography for the detection of prostate cancer.

Authors:  Georg Salomon; Jonas Schiffmann
Journal:  Curr Urol Rep       Date:  2014-03       Impact factor: 3.092

Review 3.  [Sonographic imaging of the prostate].

Authors:  B Schlenker; D A Clevert; G Salomon
Journal:  Urologe A       Date:  2014-07       Impact factor: 0.639

Review 4.  The role of diagnostic ultrasound imaging for patients with known prostate cancer within an active surveillance pathway: A systematic review.

Authors:  Pamela Parker; Maureen Twiddy; Paul Whybrow; Alan Rigby; Matthew Simms
Journal:  Ultrasound       Date:  2021-04-15

Review 5.  Application of Multiple Ultrasonic Techniques in the Diagnosis of Prostate Cancer.

Authors:  Yushan Liu; Shi Zeng; Ran Xu
Journal:  Front Oncol       Date:  2022-06-27       Impact factor: 5.738

Review 6.  A Review of Imaging Methods for Prostate Cancer Detection.

Authors:  Saradwata Sarkar; Sudipta Das
Journal:  Biomed Eng Comput Biol       Date:  2016-03-02

7.  Transrectal real-time tissue elastography targeted biopsy coupled with peak strain index improves the detection of clinically important prostate cancer.

Authors:  Qi Ma; Dong-Rong Yang; Bo-Xin Xue; Cheng Wang; Han-Bin Chen; Yun Dong; Cai-Shan Wang; Yu-Xi Shan
Journal:  Oncol Lett       Date:  2017-05-05       Impact factor: 2.967

Review 8.  Real-time elastography of the prostate.

Authors:  D Junker; T De Zordo; M Quentin; M Ladurner; J Bektic; W Horniger; W Jaschke; F Aigner
Journal:  Biomed Res Int       Date:  2014-05-22       Impact factor: 3.411

9.  Incremental learning with SVM for multimodal classification of prostatic adenocarcinoma.

Authors:  José Fernando García Molina; Lei Zheng; Metin Sertdemir; Dietmar J Dinter; Stefan Schönberg; Matthias Rädle
Journal:  PLoS One       Date:  2014-04-03       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.